Skip to search formSkip to main contentSkip to account menu

Sirdalud

Known as: Novartis brand of tizanidine hydrochloride, Sanofi Synthelabo brand of tizanidine hydrochloride 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Analysis of examination of 320 children with the spastic forms of cerebral palsy from 3 to 18 years old was carried out. All… 
2013
2013
The paper considers problems in the treatment of acute and chronic pain in patients with rheumatic diseases and shows the role of… 
1998
1998
The paper presents the results of clinical and neurophysiologic study of muscular tonus in 94 patients aged 42-70 years in early… 
Review
1997
Review
1997
The paper considers mechanisms of action and clinical efficacy of the drug sirdalud (tizanidine) in painful musculotonic… 
1997
1997
: For the first time sirdalud was used in the treatment of 32 patients with chronic form of tension-type headache. The… 
1994
1994
The activity of myorelaxant sirdalud (tizanidine) was studied in 36 patients aged 20-79 with pain syndrome (reflex muscular-tonic… 
1994
1994
Analgesic effects of morphine, clofelin, sirdalud, propranolol, and verapamil were studied in animals with the neurogenic painful…